Post-market surveillanceThyroid Analog
Compound 61863
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061863
Risk Class
HIGH
Last Audit
Sep 8, 2108
Research Abstract
Thyroid Analog candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Compound 61863 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for oncology adjuvant and inflammation control.
The dossier currently sits in post-market surveillance with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061863 with updates logged 2108-09-08.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Oncology adjuvantInflammation control
Nomenclature
CX-61863Thyroid Analog Program 61863
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061863
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61863